kaal:position:2026-07-31-3919

Mitophagy and Mitochondrial Function Regulation by Traditional Chinese Medicine Small Molecules in Cancer Therapy: Mechanisms, Challenges, and Translational Opportunities should be assessed against Kaal's source-bound claim that The current regulatory framework lacks any mechanism that anticipatorily informs rulemakers of beneficial innovative ideas, and because the rulemaking process prohibits ex parte communications and integrates cross-industry brainstorming poorly, the process may actually undermine innovation. The current metadata indicates a plausible connection through dynamic regulation, but the defensible response is a qualification until the source text confirms agreement, scope, methods, and limitations.

• notice and comment rulemaking under the existing administrative framework
• External evidence level: abstract indexed.
• Mapping review tier: ambiguity triage before claim review.
• The literature-to-claim mapping remains explicitly ambiguous and should not be treated as a settled equivalence.

Mitophagy and Mitochondrial Function Regulation by Traditional Chinese Medicine Small Molecules in Cancer Therapy: Mechanisms, Challenges, and Translational Opportunities

kaal:claim:2808132-015
Wulf A. Kaal, Erik P.M. Vermeulen, How to Regulate Disruptive Innovation - From Facts to Data (2016). SSRN: https://ssrn.com/abstract=2808132
Source PDF sha256: 3515f2317ed9c1d33ae55d70467cdf1f6c4e350065ea6a887d5d7619599ad7d2

Evidence: abstract indexed
Review tier: ambiguity triage before claim review
Mapping confidence: 0.2238
Mapping ambiguous: true

innovationdynamic-regulationregulatory-failure

Affirmed in historical-backfill:2026-07-31:phase-0016 on 2026-07-31. Review record.

Canonical markdown sha256: 03e230d8bc3c224c20cd8164975254afa7dc3d37f38f05dc38b3f8d0a191f93c
curl -s https://wulfkaal.github.io/positions/2026-07-31-3919.md | sha256sum